A National Directory of Drug Treatment Centers and Alcohol Treatment Centers, Therapists and Specialists. A free, simple directory providing assistance and guidance for those seeking help regarding alcohol addiction, drug addiction, dependency and many other conditions that affect the mind, body and soul.
Call 800-580-9104 to speak with an alcohol or drug abuse counselor.

Cancer Immunotherapy Shows Long-Term Promise In Lung Cancer

New, long-term results from a clinical trial presented today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery — to the same extent as chemotherapy but without the side-effects of chemotherapy.

Prof. Johan Vansteenkiste from University Hospital Gasthuisberg in Belgium described the results after 44-months follow-up from a double-blind, placebo-controlled trial in 182 patients with non-small-cell lung cancer — the most common form of the disease.

After complete surgical resection of the tumor, patients were randomly assigned to receive either placebo injections or injections of MAGE-A3 ASCI administered over 27 months (five given at three-week intervals followed by eight given once every three months).

MAGE-A3 is a tumor-specific antigen, expressed in 35-50% of non-small-cell lung cancer, but not on normal cells.

“The aim is to help the body immune system to recognize the MAGE-A3 antigen and therefore eliminate the cancer cells that express MAGE-A3,” explains Prof. Vansteenkiste. “In other words, it is a kind of treatment method that makes the body immune system specifically attack the lung cancer cells.”

After 44 months, 69 of 182 patients had experienced a recurrence of their cancer, including 57 deaths. Those given the MAGE-A3 injections had longer on average before their cancer recurred, were less likely to have any recurrence, and were less likely to die.

“Surgical resection is the standard treatment for patients with early stage lung cancer, but after complete resection about 50% will relapse and die from their cancer,” says Prof. Vansteenkiste. “Postoperative chemotherapy is able to improve cure rates, but is sometimes poorly tolerated by patients recovering from thoracic surgery. In addition, not all patients are fit to receive chemotherapy. This is why the signal from this phase II randomized study is important: the reduction in risk of postoperative cancer relapse is similar to the one obtained with postoperative chemotherapy, while the side-effects of this new strategy are minimal compared to chemotherapy.”

Most patients only experience mild reactions at the injection site and fever within 24 hours of the injection, he explained. “Therefore, it is suitable for long-term maintenance treatment and for most patients, including older patients or patients in weak physical condition after surgery, allowing them to live a normal life whilst on cancer treatment.” A large Phase III trial of the therapy, named MAGRIT, is now underway.

source: http://www.esmo.org/

More Treatment & Detox Articles

Alcohol Addiction

Alcohol addiction refers to a compulsive need for the intake of a liquid that is derived from a fermented fruit or a grain. These liquids are wine, beer, rum, etc. you can label a person as alcohol addicted when he craves for alcohol and is unable to limit his drinking. The craving for alcohol is….

Continue reading

Drinkers Warned About Risk Of ‘Shakes’

People who consume three alcoholic drinks every day double their risk of getting the “shakes” in later life, researchers have found. Essential tremor, a common neurological disorder, affects an estimated 650,000 people in the UK. Although there are a number of factors which can cause the condition including an overactive thyroid and Parkinson’s disease, alcoholics….

Continue reading

Faith paves the way to recovery for alcoholic

Homeless, alcoholic and hopeless, Dan Oller arrived last year at the Charlotte Rescue Mission, skeptical that its addiction treatment program could help him when 11 others had not. “There’s always that doubt in your mind, once you’ve failed over and over,” said Oller, who started drinking and doing drugs when he was 12. “I was….

Continue reading

Heavy drinkers may develop Alzheimer's earlier

Drinking or smoking heavily can speed up the development of Alzheimer’s disease, according to a new study. Scientists found that drinkers developed the disease almost five years earlier and heavy smokers just over two years earlier, after studying 938 people aged 60 or more who had been diagnosed with Alzheimer’s. Ranjan Duara, of the Mount….

Continue reading